Evaluation of Hepatic Impairment Dosing Recommendations in FDA‐Approved Product Labels

E-ISSN： 1552-4604|53|9|962-966

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.53, Iss.9, 2013-09, pp. : 962-966

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topiramate's effects on alcohol use similar to FDA‐approved drugs

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 5, 2015-05 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans

By Kaneko Yukihiro Fukazawa Hidesuke Ohno Hideaki Miyazaki Yoshitsugu

Journal of Infection and Chemotherapy, Vol. 19, Iss. 6, 2013-12 ,pp. : 1141-1145

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic breast cancer test approved by the FDA

Women's Health, Vol. 3, Iss. 2, 2007-03 ,pp. : 135-137

Future Medicine

Access to resources Recommend Favorite

Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. : 670-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Some Non‐FDA Approved Uses for Neuromodulation: A Review of the Evidence

PAIN PRACTICE, Vol. 16, Iss. 7, 2016-09 ,pp. : 935-947

John Wiley & Sons Inc

Access to resources Recommend Favorite